OTC · Medical - Devices

4DMedical Limited (FDMDF) Stock

$2.53 +0.00% OTC: FDMDF Healthcare

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging.

Valuation

MetricValue
Price$2.53
Market Cap$1.52B
P/E Ratio-12.25
P/B Ratio-69.10
P/S Ratio548.23
EPS (TTM)$-0.14
52-Week High$5.00
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-890.76%
ROA-114.36%
ROCE-38.89%
Gross Margin-396.61%
Operating Margin-483.33%
Net Margin-500.00%
Debt/Equity-0.23
Current Ratio6.57

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$1.0M$1.0M$3.0M$6.0M
Operating Profit$-14.0M$-22.0M$-31.0M$-47.0M$-29.0M
Net Profit$-21.0M$-25.0M$-31.0M$-36.0M$-30.0M
EPS$-0.08$-0.08$-0.10$-0.10$-0.14
Op Margin-6311.2%-2105.8%-4265.8%-1528.4%-499.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$93.0M$74.0M$93.0M$120.0M$95.0M
Total Liabilities$9.0M$15.0M$21.0M$49.0M$31.0M
Cash$81.0M$51.0M$70.0M$31.0M$7.0M
Borrowings$2.0M$6.0M$5.0M$5.0M$4.0M

Latest News

4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia PR Newswire · Jun 29, 2026 Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing GlobeNewswire · Jun 26, 2026 Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th GlobeNewswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-25.0M$-23.0M$-31.0M$-34.0M
Investing Cash Flow$-1.0M$-7.0M$-4.0M$-40.0M$-2.0M
Financing Cash Flow$-8.0M$-1.0M$0$-2.0M$13.0M
Net Cash Flow$72.0M$-30.0M$18.0M$-39.0M$-24.0M
Free Cash Flow$-15.0M$-28.0M$-24.0M$-31.0M$-35.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-65.54
FCF Yield-2.31%
Quick Ratio6.48
Interest Coverage-39.80
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held16.65%
Institutions Held22.48%
Institutions Float Held26.97%
Institutional HolderSharesReport Date
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund6,637,3972026-04-30
iShares Trust-iShares Core MSCI EAFE ETF5,123,6902026-06-30
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund4,211,4902026-03-31
iShares Trust-iShares MSCI EAFE Small-Cap ETF2,033,4082026-06-30
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap 1,694,1272026-04-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGYTFAllergy Therapeutics plc $0.15 +0.00% -5.05 $756.30M 0.00%
BJTRFBeijing Tong Ren Tang Chinese Medicine Company Limited $0.65 +0.00% 14.49 $542.78M 7.69%
CALZFPolynovo Limited $0.56 +0.00% 61.19 $386.87M 0.00%
CLVSFCellaVision AB (publ) $14.00 +0.00% 27.39 $333.92M 2.14%
FOGCFAvisa Diagnostics Inc. $0.00 — -0.23 $97176 0.00%

About 4DMedical Limited

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.

4DMedical Limited is headquartered in AU.

4DMedical Limited (FDMDF) stock trades at $2.53 with a market capitalization of $1.52B. The stock is valued at a price-to-earnings (P/E) ratio of -12.25, price-to-book of -69.10, price-to-sales of 548.23. Over the past 52 weeks the stock has ranged between $0.16 and $5.00, and currently trades 49.4% below its 52-week high.

On profitability, 4DMedical Limited generates a return on equity (ROE) of -890.76%, return on capital employed of -38.89%, an operating margin of -483.33%, a net profit margin of -500.00%.

Official website: www.4dmedical.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides